These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 12579297
1. Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer. Azarschab P, Stembalska A, Loncar MB, Pfister M, Sasiadek MM, Blin N. Oncol Rep; 2003; 10(2):501-3. PubMed ID: 12579297 [Abstract] [Full Text] [Related]
2. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Azarschab P, Porschen R, Gregor M, Blin N, Holzmann K. Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775 [Abstract] [Full Text] [Related]
3. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma]. Zhou YN, Xu CP, Han B, Ji R. Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136 [Abstract] [Full Text] [Related]
4. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma. Corn PG, Heath EI, Heitmiller R, Fogt F, Forastiere AA, Herman JG, Wu TT. Clin Cancer Res; 2001 Sep; 7(9):2765-9. PubMed ID: 11555590 [Abstract] [Full Text] [Related]
5. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Chang HW, Chow V, Lam KY, Wei WI, Yuen A. Cancer; 2002 Jan 15; 94(2):386-92. PubMed ID: 11900224 [Abstract] [Full Text] [Related]
6. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY. Cancer; 2007 Dec 15; 110(12):2785-92. PubMed ID: 17960794 [Abstract] [Full Text] [Related]
7. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, Karavitis G, Parassi I, Christeli E, Patrinos GP, Manolis EN, Peros G. J Pathol; 2002 Dec 15; 198(4):442-9. PubMed ID: 12434413 [Abstract] [Full Text] [Related]
8. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Chen Q, Lipkina G, Song Q, Kramer RH. Biochem Biophys Res Commun; 2004 Mar 19; 315(4):850-6. PubMed ID: 14985090 [Abstract] [Full Text] [Related]
9. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Shieh YS, Shiah SG, Jeng HH, Lee HS, Wu CW, Chang LC. Cancer; 2005 Sep 01; 104(5):1013-21. PubMed ID: 15999364 [Abstract] [Full Text] [Related]
10. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R. Mol Carcinog; 2002 Aug 01; 34(4):187-98. PubMed ID: 12203370 [Abstract] [Full Text] [Related]
11. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Yeh KT, Shih MC, Lin TH, Chen JC, Chang JY, Kao CF, Lin KL, Chang JG. Anticancer Res; 2002 Aug 01; 22(6C):3971-5. PubMed ID: 12553020 [Abstract] [Full Text] [Related]
12. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Chiles MC, Ai L, Zuo C, Fan CY, Smoller BR. Mod Pathol; 2003 Oct 01; 16(10):1014-8. PubMed ID: 14559984 [Abstract] [Full Text] [Related]
13. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K. Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757 [Abstract] [Full Text] [Related]
14. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer]. Zheng ZH, Sun XJ, Ma MC, Hao DM, Liu YH, Sun KL. Yi Chuan Xue Bao; 2003 Feb 15; 30(2):103-8. PubMed ID: 12776596 [Abstract] [Full Text] [Related]
15. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia. Corn PG, Smith BD, Ruckdeschel ES, Douglas D, Baylin SB, Herman JG. Clin Cancer Res; 2000 Nov 15; 6(11):4243-8. PubMed ID: 11106238 [Abstract] [Full Text] [Related]
16. Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors. Lombaerts M, Middeldorp JW, van der Weide E, Philippo K, van Wezel T, Smit VT, Cornelisse CJ, Cleton-Jansen AM. Biochem Biophys Res Commun; 2004 Jun 25; 319(2):697-704. PubMed ID: 15178462 [Abstract] [Full Text] [Related]
17. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. De Schutter H, Geeraerts H, Verbeken E, Nuyts S. Oncol Rep; 2009 Feb 25; 21(2):507-13. PubMed ID: 19148529 [Abstract] [Full Text] [Related]
18. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Matsumura T, Makino R, Mitamura K. Clin Cancer Res; 2001 Mar 25; 7(3):594-9. PubMed ID: 11297254 [Abstract] [Full Text] [Related]
19. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G. Gastroenterology; 2008 Dec 25; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [Abstract] [Full Text] [Related]
20. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO. Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]